Search research articles
Contact Us
Filters
Showing results (31-40 of 60) with videos related to
Page
of 6
Sort By:
Clinical Case Reports
|
May 5, 2017
The importance of functional tests to assess the effect of a new <i>CFTR</i> variant when genotype-phenotype correlation is not possible
Alexandre Hinzpeter, Marie-Pierre Reboul, Isabelle Callebaut, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 29, 2021
Pharmacological chaperones improve intra-domain stability and inter-domain assembly via distinct binding sites to rescue misfolded CFTR
Nesrine Baatallah, Ahmad Elbahnsi, Jean-Paul Mornon, et al.
Clinical Case Reports
|
December 3, 2019
Unsolved severe chronic rhinosinusitis elucidated by extensive <i>CFTR</i> genotyping
Fanny Degrugillier, Stéphanie Simon, Abdel Aissat, et al.
International Journal of Molecular Sciences
|
August 26, 2022
Differential CFTR-Interactome Proximity Labeling Procedures Identify Enrichment in Multiple SLC Transporters
Benoît Chevalier, Nesrine Baatallah, Matthieu Najm, et al.
Human Mutation
|
March 18, 2014
Identification of a novel 5' alternative CFTR mRNA isoform in a patient with nasal polyposis and CFTR mutations
Alexandre Hinzpeter, Alix de Becdelièvre, Eric Bieth, et al.
Frontiers in Pharmacology
|
January 9, 2019
The Autophagy Inhibitor Spautin-1 Antagonizes Rescue of Mutant CFTR Through an Autophagy-Independent and USP13-Mediated Mechanism
Emanuela Pesce, Elvira Sondo, Loretta Ferrera, et al.
The International Journal of Biochemistry & Cell Biology
|
October 9, 2016
Analysis of nasal potential in murine cystic fibrosis models
Mélanie Faria da Cunha, Juliette Simonin, Ali Sassi, et al.
Cellular and Molecular Life Sciences : CMLS
|
September 27, 2022
Pharmacological chaperone-rescued cystic fibrosis CFTR-F508del mutant overcomes PRAF2-gated access to endoplasmic reticulum exit sites
Kusumika Saha, Benoit Chevalier, Stéphane Doly, et al.
Plos Genetics
|
October 16, 2010
Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier
Alexandre Hinzpeter, Abdel Aissat, Elvira Sondo, et al.
Journal of Molecular Biology
|
December 25, 2022
Design of Crotoxin-Based Peptides with Potentiator Activity Targeting the ΔF508NBD1 Cystic Fibrosis Transmembrane Conductance Regulator
Marc Ravatin, Norbert Odolczyk, Nathalie Servel, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 60) with videos related to
Sort By:
Page
of 6
Clinical Case Reports
|
May 5, 2017
The importance of functional tests to assess the effect of a new <i>CFTR</i> variant when genotype-phenotype correlation is not possible
Alexandre Hinzpeter, Marie-Pierre Reboul, Isabelle Callebaut, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 29, 2021
Pharmacological chaperones improve intra-domain stability and inter-domain assembly via distinct binding sites to rescue misfolded CFTR
Nesrine Baatallah, Ahmad Elbahnsi, Jean-Paul Mornon, et al.
Clinical Case Reports
|
December 3, 2019
Unsolved severe chronic rhinosinusitis elucidated by extensive <i>CFTR</i> genotyping
Fanny Degrugillier, Stéphanie Simon, Abdel Aissat, et al.
International Journal of Molecular Sciences
|
August 26, 2022
Differential CFTR-Interactome Proximity Labeling Procedures Identify Enrichment in Multiple SLC Transporters
Benoît Chevalier, Nesrine Baatallah, Matthieu Najm, et al.
Human Mutation
|
March 18, 2014
Identification of a novel 5' alternative CFTR mRNA isoform in a patient with nasal polyposis and CFTR mutations
Alexandre Hinzpeter, Alix de Becdelièvre, Eric Bieth, et al.
Frontiers in Pharmacology
|
January 9, 2019
The Autophagy Inhibitor Spautin-1 Antagonizes Rescue of Mutant CFTR Through an Autophagy-Independent and USP13-Mediated Mechanism
Emanuela Pesce, Elvira Sondo, Loretta Ferrera, et al.
The International Journal of Biochemistry & Cell Biology
|
October 9, 2016
Analysis of nasal potential in murine cystic fibrosis models
Mélanie Faria da Cunha, Juliette Simonin, Ali Sassi, et al.
Cellular and Molecular Life Sciences : CMLS
|
September 27, 2022
Pharmacological chaperone-rescued cystic fibrosis CFTR-F508del mutant overcomes PRAF2-gated access to endoplasmic reticulum exit sites
Kusumika Saha, Benoit Chevalier, Stéphane Doly, et al.
Plos Genetics
|
October 16, 2010
Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier
Alexandre Hinzpeter, Abdel Aissat, Elvira Sondo, et al.
Journal of Molecular Biology
|
December 25, 2022
Design of Crotoxin-Based Peptides with Potentiator Activity Targeting the ΔF508NBD1 Cystic Fibrosis Transmembrane Conductance Regulator
Marc Ravatin, Norbert Odolczyk, Nathalie Servel, et al.
Page
of 6